Health
Phase 3 trial: New biologic therapy improves outcomes in adults, adolescents with severe asthma – News-Medical.Net
Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency…
Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency department (ED) visits for adults and adolescents with severe, uncontrolled asthma, according to research presented at the ATS 2021 International Conference. NAVIGATOR (NCT03347279) is a recently completed randomized, placebo-controlled double-blind multicenter phase 3 clinical trial.
Tezepelumab offers new therapeutic opportunities for patients…
-
Noosa News24 hours agoMan avoids jail for assaulting Brisbane bus driver, appears from custody on unrelated charges
-
General14 hours agoAs Iran-Australia relations plunge to a new low, Tehran faces another diplomatic setback
-
General21 hours agoPolice offer ‘surrender plan’ to Dezi Freeman as fugitive avoids capture for another day
-
General20 hours agoGeelong Cats AFL star Bailey Smith details mental health battle during All-Australian speech